ClearBridge Investments’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $219M | Buy |
5,130,774
+2,851,356
| +125% | +$155M | 0.18% | 132 |
|
|
2026
Q1 | $143M | Buy |
2,279,418
+1,546,181
| +211% | +$124M | 0.12% | 164 |
|
|
2025
Q4 | $69.9M | Buy |
733,237
+730,376
| +25,529% | +$71.6M | 0.06% | 282 |
|
|
2025
Q3 | $279K | Sell |
2,861
-79
| -3% | -$8.18K | ﹤0.01% | 698 |
|
|
2025
Q2 | $316K | Sell |
2,940
-78
| -3% | -$7.89K | ﹤0.01% | 681 |
|
|
2025
Q1 | $304K | Sell |
3,018
-289
| -9% | -$29.1K | ﹤0.01% | 679 |
|
|
2024
Q4 | $295K | Sell |
3,307
-892
| -21% | -$78.5K | ﹤0.01% | 692 |
|
|
2024
Q3 | $352K | Sell |
4,199
-1,529
| -27% | -$121K | ﹤0.01% | 689 |
|
|
2024
Q2 | $441K | Sell |
5,728
-449
| -7% | -$32.9K | ﹤0.01% | 705 |
|
|
2024
Q1 | $423K | Sell |
6,177
-60
| -1% | -$3.86K | ﹤0.01% | 715 |
|
|
2023
Q4 | $361K | Buy |
6,237
+767
| +14% | +$40.9K | ﹤0.01% | 720 |
|
|
2023
Q3 | $289K | Sell |
5,470
-1,034
| -16% | -$54.2K | ﹤0.01% | 672 |
|
|
2023
Q2 | $352K | Sell |
6,504
-14
| -0.2% | -$731 | ﹤0.01% | 675 |
|
|
2023
Q1 | $326K | Sell |
6,518
-45
| -0.7% | -$2.12K | ﹤0.01% | 686 |
|
|
2022
Q4 | $304K | Buy |
+6,563
| New | +$284K | ﹤0.01% | 715 |
|
|
2022
Q2 | – | Sell |
-4,745
| Closed | -$210K | – | 767 |
|
|
2022
Q1 | $210K | Sell |
4,745
-578
| -11% | -$25K | ﹤0.01% | 773 |
|
|
2021
Q4 | $226K | Hold |
5,323
| – | – | ﹤0.01% | 774 |
|
|
2021
Q3 | $231K | Buy |
+5,323
| New | +$235K | ﹤0.01% | 776 |
|
|
2020
Q4 | – | Sell |
-7,415
| Closed | -$283K | – | 796 |
|
|
2020
Q3 | $283K | Sell |
7,415
-1,356
| -15% | -$52.3K | ﹤0.01% | 750 |
|
|
2020
Q2 | $308K | Buy |
8,771
+235
| +3% | +$8.46K | ﹤0.01% | 699 |
|
|
2020
Q1 | $279K | Sell |
8,536
-3
| -0% | -$117 | ﹤0.01% | 681 |
|
|
2019
Q4 | $387K | Buy |
8,539
+69
| +0.8% | +$2.89K | ﹤0.01% | 696 |
|
|
2019
Q3 | $345K | Sell |
8,470
-293
| -3% | -$12.4K | ﹤0.01% | 711 |
|
|
2019
Q2 | $377K | Buy |
8,763
+2,111
| +32% | +$81.2K | ﹤0.01% | 709 |
|
|
2019
Q1 | $255K | Sell |
6,652
-3
| -0% | -$115 | ﹤0.01% | 740 |
|
|
2018
Q4 | $235K | Buy |
6,655
+417
| +7% | +$15.1K | ﹤0.01% | 762 |
|
|
2018
Q3 | $240K | Buy |
6,238
+3,010
| +93% | +$105K | ﹤0.01% | 796 |
|
|
2018
Q2 | $106K | Buy |
+3,228
| New | +$97.4K | ﹤0.01% | 768 |
|
|
2016
Q1 | – | Sell |
-236
| Closed | -$4K | – | 1062 |
|
|
2015
Q4 | $4K | Buy |
+236
| New | +$4.23K | ﹤0.01% | 1077 |
|
|
2014
Q1 | – | Sell |
-215
| Closed | -$3K | – | 1130 |
|
|
2013
Q4 | $3K | Hold |
215
| – | – | ﹤0.01% | 1089 |
|
|
2013
Q3 | $3K | Hold |
215
| – | – | ﹤0.01% | 1073 |
|
|
2013
Q2 | $2K | Buy |
+215
| New | +$1.82K | ﹤0.01% | 1058 |
|
Other funds holding BSX
ClearBridge Investments's BSX Position: Q2 2026 in Review
ClearBridge Investments increased its Boston Scientific (BSX) stake by 125% in Q2 2026, buying an estimated $155M and bringing the position to 5,130,774 shares worth $219M. The position accounts for 0.18% of the portfolio, ranked #132.
ClearBridge Investments first reported a position in BSX in Q2 2013 and has held it in 32 quarters since. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- ClearBridge Investments held 5,130,774 shares of Boston Scientific worth $219M as of Q2 2026.
- ClearBridge Investments bought 2,851,356 Boston Scientific shares in Q2 2026, an estimated $155M.
- Boston Scientific made up 0.18% of ClearBridge Investments's portfolio in Q2 2026, its #132 holding.
- ClearBridge Investments first reported a position in Boston Scientific in Q2 2013 and has held it in 32 quarters since.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.